|
|
Health Professionals Guide to Newborn Screening
Organic Acidemia Disorders
Organic Acidemias (OA) are a class of inherited metabolic disorders that lead to accumulation of organic acids in biological fluids (blood and urine). This, in turn, produces disturbances in the acid-base balance and causes alterations in pathways of intermediary metabolism. Clinical symptoms of OA disorders may include vomiting, metabolic acidosis, ketosis, dehydration or coma, hyperammonemia, lactic acidosis, hypoglycemia, failure to thrive, hypotonia, global developmental delay, sepsis and hematological disorders.
| Analyte Measured: |
Acylcarnitine profiling by Tandem Mass Spectrometry |
| Disorders Reported, Reporting Ranges and Prevalence: |
|
Disorder
|
Abbrev.
|
Abnormal Acylcarnitine(s) uM
|
Prevalence (estimated)
|
| Glutaryl CoA Dehydrogenase Deficiency Type I GA-I |
GA1 |
C5DC ≥0.10 |
1:92,000 |
|
Propionyl CoA Carboxylase Deficiency
|
PA |
C3≥ 6.92 C3/C2≥0.20 |
1:150,000 |
|
Methylmalonic Acidemia: mutase Clb A & B Clb C & D
|
MMA |
C3 ≥ 6.92 C3/C2 ≥ 0.30 |
1:46,000* |
Isovaleryl CoA Dehydrogenase Deficiency 2-Methylbutyryl CoA dehydrogenase Deficiency |
IVA 2MBCD |
C5 ≥ 0.44 C5/C3 ≥ 0.50 C5/C2 ≥ 0.05 |
1:92,000 1:13,000
|
| 3-Methylcrontonyl CoA Carboxylase Deficiency |
3-MMC |
C5OH ≥ 0.60 |
1:29,000 |
|
Mitochondrial Acetoacetyl CoA Thiolase Deficiency 2-Methyl-3-Hydroxbutyryl CoA Dehydrogenase
|
b-KT MHBD |
C5:1 ≥ 0.13 C5OH ≥ 0.60 |
1:460,000 Unknown |
| 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency |
HMG |
C5OH ≥ 0.60 C6DC ≥ 0.20 |
Unknown |
| Multiple CoA Carboxylase Deficiency |
MCD |
C5OH ≥ 0.60 C3 ≥ 6.92 |
Unknown |
| Isobutyryl CoA Dehydrogense Deficiency |
IBD |
C4 ≥ 1.20 |
Unknown |
| 3 Methylglutaconyl CoA Hydrastase Deficiency |
3MGA |
C6DC ≥ 0.20 |
Unknown |
* Includes benign and mild cases |
| Feeding Effect: |
None |
| Timing Effect: |
Early specimen collections may enhance the detection of these disorders. |
| Confirmation: |
Referral to metabolic center for urine organic acids analysis, specific enzyme analysis and/or mutation analysis. |
|
Treatment:
|
Low protein diet, carnitine or vitamin supplements, avoid fasting |
Information on treatment centers is also available on this site.
For information about other screened disorders, click on the next page button, or follow one of these links:
NEXT PAGE
|